Product Name :
Futibatinib
Search keywords :
Heparin
drugId :
null
Target Vo:
Fibroblast growth factor receptor 4
Target Vo Short Name :
FGFR4
Moa_Name:
Fibroblast growth factor receptor 4 antagonists
First Approval Country :
United States
First Approval Date Filter:
2022
Origin Company_Name :
Taiho Pharmaceutical Co Ltd
Active Company_Name :
Institut National De La Santé Et De La Recherche Médicale, France U979
Active Indication_Name:
Cholangiocarcinoma
In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung
Termination Status :
China Termination Status :
Highest Status:
Approved
China Highest Status:
Phase 2 Clinical
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Hsp70 1A Antibody (YA727)
GSK3 beta Antibody (YA397)
Myogenin Antibody: Myogenin Antibody is an unconjugated, approximately 25 kDa, rabbit-derived, anti-Myogenin polyclonal antibody. Myogenin Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in (predicted) human, mouse, rat, pig, cow, horse, rabbit, sheep background without labeling.